Cas 139130-53-3,Thiazole, 2-(methoxymethyl)-

139130-53-3

Post Buying Request

Basic information

Product Name: Thiazole, 2-(methoxymethyl)-
Synonyms: Thiazole, 2-(methoxymethyl)-
CAS NO:139130-53-3
Molecular Formula: C5H7NOS
Molecular Weight: 0
EINECS: N/A
Product Categories: N/A
Mol File: 139130-53-3.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: /
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Thiazole, 2-(methoxymethyl)-(CAS DataBase Reference)
NIST Chemistry Reference: Thiazole, 2-(methoxymethyl)-(139130-53-3)
EPA Substance Registry System: Thiazole, 2-(methoxymethyl)-(139130-53-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 139130-53-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

139130-53-3 Suppliers

Recommended suppliers

139130-53-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 139130-53-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,9,1,3 and 0 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 139130-53:
(8*1)+(7*3)+(6*9)+(5*1)+(4*3)+(3*0)+(2*5)+(1*3)=113
113 % 10 = 3
So 139130-53-3 is a valid CAS Registry Number.

139130-53-3Upstream product

139130-53-3Downstream Products

877398-86-2 2-(methoxymethyl)thiazole-5-carbaldehyde

139130-53-3Relevant academic research and scientific papers

THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS

-

Page/Page column 95; 96, (2021/04/02)

Provided herein are compounds of Formula (I) and Formula (II) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of tuberculosis.

Dihydroisoquinoline compound

-

Paragraph 0449; 0455-0457, (2020/07/24)

The invention provides a dihydroisoquinoline compound or a pharmaceutically acceptable salt, ester, isomer, solvate, hydrate, prodrug or isotope marker thereof. The compound has a structure shown as ageneral formula I. The compound has extremely strong activity of inhibiting hepatitis B surface antigen, also has extremely strong activity of inhibiting hepatitis B DNA, has relatively high bioavailability, can play a drug effect at a relatively low dosage, and reduces the potential toxicity of the compound.

COMPOUNDS AND USES THEREOF

-

Paragraph 0617, (2019/11/11)

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

-

Page/Page column 75, (2014/08/06)

The present invention relates to novel Heterocycle-Substituted Tetracyclic Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, A', R 2 R 3, R 4 and R are as defined herein. The present i

THIAZOLYL-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

-

Page/Page column 56; 57, (2014/08/06)

The present invention relates to novel Thiazolyl-Substituted Tetracyclic Compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein A, A', R2R3, R4 and R5 are as defined herein. The present

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 139130-53-3